Vol 2, No 5 (October 2013): Translational Lung Cancer Research (Management of early stage non-small cell lung cancer - Guest Editor: Heather Wakelee)

Review Articles

Interventional pulmonology approaches in the diagnosis and treatment of early stage non small cell lung cancer
Ryu Peter Hambrook Tofts, Peter MJ Lee, Arthur Wai Sung
Alternatives to surgery in early stage disease—stereotactic body radiotherapy
Meredith Elana Giuliani, Andrea Bezjak
Alternative to surgery in early stage NSCLC—interventional radiologic approaches
Kyungmouk Steve Lee, Bradley B. Pua
Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
Yoshihisa Kobayashi, Tetsuya Mitsudomi
Towards optimal pathologic staging of resectable non-small cell lung cancer
Raymond U. Osarogiagbon, Gail E. Darling
Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures
Simona Carnio, Silvia Novello, Mauro Papotti, Marco Loiacono, Giorgio Vittorio Scaglio
Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers
Philip A.J. Crosbie, Rajesh Shah, Yvonne Summers, Caroline Dive, Fiona Blackhall
Neoadjuvant chemotherapy in early-stage non-small cell lung cancer
Francesc Salvà, Enriqueta Felip
Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
Ying Liang, Heather A. Wakelee